Aleema Khanum and Noreen Niazi said in a post on X that only two brief notes were submitted in court instead of a detailed report, calling it “a complete disregard for the authority of the Supreme ...
PIMS Executive Director Prof Dr Rana Imran Sikandar submitted the report to superintendent of Rawalpindi's Adiala Jail on the ...
PTI founder received successful treatment for right eye at PIMS Islamabad, diagnosed with retinal vein occlusion, discharged ...
Interesting Engineering on MSN
First-ever experimental gene therapy seeks to restore vision by rejuvenating eye neurons
Life Biosciences is pushing cellular rejuvenation into the clinic with ER-100, an experimental gene ...
Safety and clinical outcomes of Phase 1 study of VCN-01 (zabilugene almadenorepvec) in refractory retinoblastoma patients to be presented in an ...
The authors noted that this is the first prospective case series to apply a structured, protocol-based approach to ...
1) the active drug substance Axitinib, which used to belong to Pfizer, is an FDA-approved, oral, potent VEGFR inhibitor. So ...
To learn more about this topic, including the diagnosis and interdisciplinary management of MacTel, go to ...
The sisters of Pakistan Tehreek-e-Insaf (PTI) founder Imran Khan urged Chief Justice of Pakistan (CJP) Yahya Afridi on Friday ...
Enzeevum, a biosimilar to Eylea, is approved in Canada for multiple retinal conditions, expanding treatment options for ophthalmologists. Biosimilars may offer cost-effective alternatives, potentially ...
With a strong presence in Canada, Australia and New Zealand, Sandoz is committed to helping millions of patients access ...
Belite Bio (BLTE) stock outlook: tinlarebant clinical data, 2026 filings, key FDA/EU risks, and $165/share valuation. See if ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results